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INTRODUCTION
Human immunodeficiency virus type1 (HIV-1)
carries several auxiliary genes not found in the other
simple retroviruses (1). Of the six auxiliary genes,
four accessory genes designated nef, vif, vpr, and
vpu are dispensable for viral replication at least in
certain types of cells (2-5). However, the products
of these accessory genes certainly modulate virus
replication in tissue culture systems, and more
importantly, virus replication and pathogenesis in
vivo . Of the four accessory proteins, Vpu is always
non-essential for virus replication in any kinds of cells
tested (6-11), although it has been demonstrated
to enhance virion release from cells of various types
(8,12). Even in natural target cells such as periph-
eral blood mononuclear cells (PBMCs), vpu mutant
viruses grow quite well (9, 11). It is possible, however,
that the results described above may not be general,
and may be dependent on the vpumutant clones (10)
and cells used in the experiments. It has been reported
that vpu mutants grow very poorly in macrophage
cultures (7, 9).
In this study, a vpumutant, which lacks the expres-
sion of the entire vpu gene, was newly constructed
and monitored for its replication in various types of
cells in comparison with another mutant expressing
a truncated form of Vpu (13) and a wild-type (wt)
clone. We show here that this new vpu mutant does
replicate in two lymphocytic cell lines and in all
PBMC cultures of six individuals, thus demonstrat-
ing the dispensability of the HIV-1 Vpu for virus
replication in lymphocytic cells.
MATERIALS AND METHODS
Cells, transfection, and infection
A human cervical carcinoma cell line, HeLa (ATCC
CCL2), was maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% heat-inactivated
fetal calf serum. CD4-positive human lymphocytic
cell lines A3.01 (14) and CEMx174 (15) were main-
tained in RPMI1640 medium supplemented with 10%
heat-inactivated fetal calf serum. Human PBMCs
were prepared and cultured as previously described
(16). For transfection, uncleaved plasmid DNA was
introduced into HeLa cells by the calcium-phosphate
coprecipitation method (17). Cells were infected with
cell-free virus samples prepared from transfections
as previously described (14, 18).
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RT assay
Virion-associated reverse transcriptase (RT) activity
was measured as described previously (19).
Western blotting
Western immunoblotting was performed as pre-
viously described (19). MULTI GEL system (Daiichi
Pure Chemicals) was used for polyacrylamide gel
electrophoresis. Specific viral Vpu protein was
detected by the ECL system (Amersham) using an
antibody, a generous gift from Dr. Klaus Strebel,
raised against amino acids 33-81 of the HIV-1 Vpu
(C-terminus) (20). A serum of an individual infected
with HIV-1 was also used for detection of viral
structural proteins.
DNA constructs
Molecular clones of HIV-1 designated pNL432
and pNL-Ss have been previously described (8, 13,
17, 21). A vpu mutant clone pNL-E65, which lacks
the initiation codon (AGG instead of ATG), was
constructed by the LA PCR in vitro Mutagenesis Kit
(Takara). The structure of this mutant was confirmed
by dideoxy sequencing.
RESULTS
Western blot analysis of vpu mutants
Our previous genetic studies (8, 11, 13, 21) involved
the use of a mutant, NL-Ss, which carries a linker
insertion resulting in a translational frameshift after
the first 32 amino acids of Vpu like a mutant desig-
nated Vpu35 (10, 22) and therefore has the potential
to express the entire N-terminal transmembrane
(TM) domain (22). We constructed a second HIV-1
vpumutant , NL-E65, which lacks the initiation codon
and is therefore unable to express any Vpu-specific
sequence. The parental clone of the two vpu mutants
was T-cell tropic pNL432 (17). We first confirmed
the inability of our new vpumutant NL-E65 to express
the Vpu protein. HeLa cells were transfected with
various clones, and cell lysates were made at 2 days
post-transfection. The expression of Vpu was moni-
tored by Western blotting analysis. As shown in
Fig.1A, the two vpu mutants were able to produce
viral structural proteins normally upon transfection.
In contrast, as shown in Fig.1B, the mutants did not
generate Vpu detectable by the anti-Vpu antiserum,
as was expected.
Growth property of vpu mutant viruses in established
cell lines
When inoculated into CD4-positive cell lines,
HIV-1 vpu mutant viruses display unique and char-
acteristic growth curves (6, 8, 12, 22). Namely, the
growth kinetics of the vpu mutant virus are similar
to those of wt virus but the expression of virus pro-
duction in culture medium is much lower than that
of wt virus.
Fig.1. Western blot analysis of HIV-1 vpu mutants. HeLa cells
were transfected with a negative control pUC119 (a), wt pNL432
(b), mutant pNL-Ss (c), or mutant pNL-E65 (d), and cell lysates
were made 48 hr later. The expression of structural proteins (A)
and of Vpu protein (B) was monitored by Western blot analysis
using a serum from an HIV-1 infected individual (A) and an
antiserum raised against C-terminal portion of Vpu (B). Note the
presence of HIV-1 Env (gp160, gp120), Pol (p66), Gag (p55,
p24, p17) in lanes b to d in (A). Molecular weights in kDa are
indicated on the left.
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We initially examined the growth
property of a new HIV-1vpu mutant virus
derived from transfection of plasmid
pNL-E65 in two CD4-positive cell lines.
HeLa cells were transfected with various
clones, and cell-free virus samples were
prepared at 2 days post-transfection. As
shown in Fig.2, in A3.01 and CEMx174
cells, both vpu mutants, NL-Ss (8, 13)
and NL-E65, showed the growth charac-
teristics typical to the vpu mutant.
Growth property vpu mutant viruses in
PBMCs
To determine whether Vpu is critical
for the replication of HIV-1 in natural
target cells, we monitored the growth
potential of the NL-E65 vpu mutant
virus in stimulated and unstimulated
PBMCs. Our previous study using a
vpu mutant of macrophage tropic clone
has shown that Vpu is quite important
for virus replication in macrophages (7).
However, only a mild effect of vpu muta-
tion on virus replication was observed
in PBMCs, (7, 11).
Cell-free virus samples were prepared
as described above, and inoculated into
PBMCs prepared from six healthy indi-
viduals. We were especially interested
in infection of unstimulated PBMCs with
NL-E65. It has been recently reported
that the accessory protein Nef is very
important for virus replication in the
unstimulated cells (18). As shown in
Fig.3, in stimulated PBMCs, both vpu
mutants grew considerably well relative
to wt virus in the all six independent
preparations as reported previously (11).
This was the case in most unstimulated
PBMC preparations, as shown in Fig.4.
Although the peak level of virus produc-
tion varied, the two vpu mutants grew
relatively well. In one unstimulated PBMC
preparation, the two vpu mutants, espe-
cially NL-E65, grew very poorly relative
to wt virus (Fig.4B).
DISCUSSION
The major conclusion of this study is
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Fig.3. Growth property of HIV-1 vpu mutants in stimulated PBMCs. Stimulated
PBMCs were prepared and infected with the virus essentially as described
previously (cells were isolated and activated with PHA-P before infection) (18).
Cells (105) were infected with 105 RT units of cell-free virus samples prepared
from transfected HeLa cells, and RT production in the culture media was
determined at the designated intervals. Symbols : ○, mock-infection ; ●, NL432
(wt) ; ▲, NL-Ss (vpu mutant) ; ■, NL-E65 (vpu mutant).
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Fig.2. Growth property of HIV-1 vpu mutants in A3.01 and CEMx174 cell lines.
A3.01 (A) and CEMx174 (B) cells (106) were infected with 4 x105 RT units of
cell-free virus samples prepared from transfected HeLa cells, and RT production
in the culture media was determined at the designated intervals. Symbols : ○,
mock-infection ; ●, NL432 (wt) ; ▲, NL-Ss (vpu mutant) ; ■, NL-E65 (vpu
mutant).
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that the HIV-1 Vpu is dispensable for virus
replication in any types of CD4-positive
cells. Although a critical requirement of
Vpu for HIV-1 growth in macrophages
has been reported previously (7, 9), HIV-1
lacking the entire vpu gene could replicate
to some extent in all the cell types tested
so far. Whether the Vpu is essential for
HIV-1 replication in cells other than those
examined to date needs to be determined.
It is also possible that Vpu plays an impor-
tant functional role for in vivo replication
and pathogenesis like Nef and Vpr (2-5).
It has been reported that the HIV-1
Vpu has two structural domains which
are important for two distinct biological
activities (10). The TM and cytoplasmic
regions represent active domains for the
regulation of virus release from cells and
the CD4 degradation in cells, respectively.
The results of our experiments described
here suggest that the TM region of the
Vpu does not contribute much to the
growth property of the vpumutant. Further
genetic study is required to determine
the functional domains of HIV-1 Vpu.
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